Isotretinoin and iPledge: a view of results

J Am Acad Dermatol. 2011 Aug;65(2):418-419. doi: 10.1016/j.jaad.2011.04.006.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Abnormalities, Drug-Induced / prevention & control*
  • Adverse Drug Reaction Reporting Systems / organization & administration*
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use
  • Female
  • Humans
  • Isotretinoin / adverse effects*
  • Isotretinoin / therapeutic use
  • Pregnancy
  • Pregnancy Complications / chemically induced
  • Pregnancy Complications / prevention & control*
  • Program Development
  • Program Evaluation
  • United States
  • United States Food and Drug Administration

Substances

  • Dermatologic Agents
  • Isotretinoin